Sign in

CIK 0001372514

  • Non-accelerated filer
  • Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980443284
Phone
+1 858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-28 MANZO MICHAEL P. Vice President of Engineering Grant or award · Stock Option (right to buy) +25,000 25,000
2018-02-28 Wirostko Barbara Chief Medical Officer Grant or award · Stock Option (right to buy) +25,000 25,000
2018-02-28 FROM STEPHEN President and CEO Grant or award · Stock Option (right to buy) +150,000 150,000
2017-12-29 Romano Sarah Chief Financial Officer Other acquisition +11,863 $1.01 $12K 44,363
2017-12-29 Wirostko Barbara Chief Medical Officer Other acquisition +12,355 $1.01 $12K 240,397
2017-12-29 Mann Brenda VP of Research & Development Other acquisition +6,722 $1.01 $7K 18,473
2017-12-29 FROM STEPHEN President and CEO Other acquisition +12,355 $1.01 $12K 284,820
2017-11-17 Garanzini Michael Chief Commercial Officer Grant or award +15,000 $1.07 $16K 15,000
2017-11-17 Garanzini Michael Chief Commercial Officer Grant or award · Stock Option (right to buy) +85,000 85,000
2017-09-15 Wirostko Barbara Chief Medical Officer Grant or award +9,000 $1.20 $11K 228,042
2017-09-14 Wirostko Barbara Chief Medical Officer Grant or award +1,200 $1.22 $1K 219,042
2017-09-14 Wirostko Barbara Chief Medical Officer Grant or award +9,000 $1.23 $11K 50,700
2017-08-15 Romano Sarah Interim CFO Purchase +10,000 $1.00 $10K 32,500
2017-08-10 FROM STEPHEN President and CEO Purchase +12,500 $1.03 $13K 272,465
2017-06-21 MANZO MICHAEL P. Vice President of Engineering Grant or award · Stock Option (right to buy) +20,000 20,000
2017-06-21 Romano Sarah Interim CFO Grant or award · Stock Option (right to buy) +40,000 40,000
2017-06-21 Mann Brenda VP of Research & Development Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-21 Wirostko Barbara Chief Medical Officer Grant or award · Stock Option (right to buy) +35,000 35,000
2017-06-21 FROM STEPHEN President and CEO Grant or award · Stock Option (right to buy) +125,000 125,000
2017-06-21 HANCOCK THOMAS Director Grant or award · Stock Option (right to buy) +15,000 15,000

Page 22 of 24 · 468 trades